Research Highlights

Discoveries and Innovations

  • Helped develop lifesaving procedures including angioplasty and drug-eluting stents, and newer technologies such as off-pump surgery.
  • Created lamivudine (3TC) and emtricitabine (FTC), two of the most commonly used and most successful HIV/AIDS drugs, taken by more than 94% of U.S. patients on therapy and by thousands more around the world
  • Developed one of the leading vaccine candidates against HIV, already tested in preclinical and early stage clinical trials and currently in phase II trials
  • Developed brain mapping to guide effective surgical approaches (deep brain stimulation) to treat movement disorders such as Parkinson's and dystonia
  • Discovered the gene responsible for fragile X syndrome, the most common cause of inherited intellectual disability, and now working to develop drug therapy to treat it.
  • Helped develop belatacept, a post-transplant drug that is less toxic and more effective than current immunosuppressants.
  • Discovered the role of PD-1 (programmed cell death 1) in inhibiting the T cell immune response to chronic viral infections, also paving the way for new cancer immunotherapy drugs.
  • Developing an effective method of using deep-brain stimulation as therapy for treatment-resistant severe depression.

Research Leadership

  • Winship Cancer Institute of Emory University is the only National Cancer Institute-designated cancer center in Georgia.
  • The Yerkes National Primate Research Center of Emory University is one of only eight NIH-designated national primate research centers in the country.
  • Emory is one of eight NIH-sponsored Vaccine Evaluation and Treatment Units (VTEUs) conducting clinical trials for vaccines for infectious diseases, including H1N1 flu. 
  • Emory is a leader in technology transfer, with more than 39 products having reached the marketplace. Over the past two decades, the WHSC has helped Emory launch 72 start-up companies and bring more than $854 million into Georgia in licensing revenues from drugs, diagnostics, devices, and consumer products.
  • The research partnership between Emory and Georgia Tech includes the No. 2-ranked (U.S. News & World Report) Wallace H. Coulter Department of Biomedical Engineering, the Georgia Tech-Emory Center for Regenerative Medicine (GTEC), the Emory/Georgia Tech Predictive Health Institute, and one of the nation's largest NIH-funded research programs in nanomedicine.

External Research Funding

  • Emory University total external research funding, FY15: $572.4 million
  • Woodruff Health Sciences Center external research funding, FY15: $537 million 
  • Emory University funding by federal agencies, FY15: $375 million
  • Emory University NIH funding, FY15: $300 million